Article Information
- February 27, 2023.
Article Versions
- Version 1 (February 5, 2022 - 00:00).
- You are viewing Version 2, the most recent version of this article.
REVISION SUMMARY
We performed a benchmarking study of our gene discovery tool, Mapgen. We provided additional background on the statistical fine-mapping technique in the Results section and also added a new section in Methods with details of how fine-mapping was performed in our study. We significantly extended the discussion of related work that aimed to identify risk variants and genes underlying genetics of atrial fibrillation. We now include a comparison of our data with published single-cell dataset in the heart, validating our cell type assignments. We significantly revised the introduction of the eQTL section in the Results part.
Author Information
- Alan Selewa1,*,
- Kaixuan Luo2,*,
- Michael Wasney3,+,
- Linsin Smith4,+,
- Xiaotong Sun2,+,
- Chenwei Tang5,
- Heather Eckart3,
- Ivan P. Moskowitz2,6,
- Anindita Basu3,†,
- Xin He2,#,† and
- Sebastian Pott3,#,†
- 1Biophysical Sciences Graduate Program, The University of Chicago, Chicago, IL 60637, USA
- 2Department of Human Genetics, The University of Chicago, Chicago, IL 60637, USA
- 3Department of Medicine, Section of Genetic Medicine, The University of Chicago, Chicago, IL 60637, USA
- 4Committee on Genetics, Genomics and Systems Biology, The University of Chicago, Chicago, IL 60637, USA
- 5The College, The University of Chicago, Chicago, IL 60637, USA
- 6Department of Pediatrics, The University of Chicago, Chicago, IL 60637, USA
- ↵†Correspondence: obasu{at}uchicago.edu, xinhe{at}uchicago.edu, spott{at}uchicago.edu
↵*, +, # These authors contributed equally.